CELLULAR BIOMEDICINE GROUP, INC.: 10-Q filed 2012-11-09
What CELLULAR BIOMEDICINE GROUP, INC. reported in its quarterly report filed 2012-11-09 (fiscal Q3 2012): 25 published measures, 71 facts as tagged in accession 0001354488-12-005685.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-11-09
- Fiscal period
- fiscal Q3 2012
- Accession
- 0001354488-12-005685 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All CELLULAR BIOMEDICINE GROUP, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 6,736,816 | USD | |
| At 2011-12-31 | 1,545,230 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 4,553,785 | USD | |
| At 2011-12-31 | 1,970,886 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 2,183,031 | USD | |
| At 2011-12-31 | -425,656 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 5,163,560 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 4,747,460 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -75,022 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -744,483 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | -586,849 | USD | 274 |
| 2011-01-01 to 2011-09-30 | -193,600 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 5,887,057 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 6,053,828 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 3,000 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 31,000 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | -15,898 | USD | 274 |
| 2011-01-01 to 2011-09-30 | 144,054 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | -4,095,088 | USD | |
| At 2011-12-31 | -6,592,860 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | 109 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 5,563,961 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 5,166,322 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -358,709 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -1,022,029 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 50,000 | USD | |
| At 2011-12-31 | 602,747 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -501 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 902 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -1,853 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -7,899 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 4,553,785 | USD | |
| At 2011-12-31 | 1,970,886 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 212,649 | USD | |
| At 2011-12-31 | 189,296 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 323,096 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 887,506 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 361,709 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 1,053,029 | USD | 273 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 5,887,057 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 6,053,828 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 3,000 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 31,000 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 156,692,041 | shares | |
| At 2011-12-31 | 154,590,189 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | -45,694 | USD | |
| At 2011-12-31 | -22,847 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 1,165,665 | USD | |
| At 2011-12-31 | 982,003 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 5,163,560 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 4,747,569 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -75,022 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -744,483 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 5,140,713 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 4,701,766 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -154,987 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -778,754 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 301,190 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 827,369 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 348,032 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 977,701 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 400,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 425,883 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -232,852 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -232,757 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 400,401 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 418,753 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -283,687 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -277,546 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | 55,793 | USD | 274 |
| 2011-01-01 to 2011-09-30 | -157,238 | USD | 273 |
Inspect the source
- Entity
- CELLULAR BIOMEDICINE GROUP, INC. / CIK 0001378624
- Captured
- SEC response SHA-256
b44d08863d62569e9fd817107b545bcd8036e0b5a0651202c09ca062cee0088a
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001378624.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))